Potassium Chloride Ph. Eur., Sodium Hydrogen Carbonate Pheur, Sodium Chloride Ph. Eur.

5 trials 2 recruiting BHaematology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

2 Recruiting

2 Completed trials

4 Sponsors

10 Countries

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 2 Phase IV: 2

Indications tested

Cardiac amyloidosis 1 Septic coagulopathy 1

Sponsors using this IMP

Les Hopitaux Universitaires De Strasbourg 2 Alexion Pharmaceuticals Inc. 1 Leids Universitair Medisch Centrum (LUMC) 1 Novo Nordisk A/S 1

All trials

5 total

Phase IIb Multicenter Randomized Controlled Trial Evaluating the Efficacy of Sivelestat in Patients with Septic Coagulopathy Pending

2025-523397-16-00 Phase II 1 country Les Hopitaux Universitaires De Strasbourg
Optimization of pain management for acute renal colic in the Emergency Department – The OPTIMIZED trial Recruiting

2025-521316-19-00 Phase IV 1 country Leids Universitair Medisch Centrum (LUMC)
Evaluation of 200 mg of Rituximab every 6 months as maintenance treatment of Rituximab-treated patients with rheumatoid arthritis: a non-inf… Recruiting

2024-519991-18-00 Phase IV 1 country Les Hopitaux Universitaires De Strasbourg
A research study to look at long-term treatment with a medicine called NNC6019-0001 for people who have heart failure due to transthyretin a… Ended

2022-502605-15-00 Phase II 7 countries Novo Nordisk A/S
A double-blind study to evaluate the effectiveness and safety of CAEL-101 in patients with AL amyloidosis. Ended

2022-503072-84-00 Phase III 8 countries Alexion Pharmaceuticals Inc.

Showing 1–5 of 5 trials

← All drugs A–Z